Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JVSPAC Acquisition | JVSAU | Nov 7, 2024 | 10.90 | 0.00 |
JVSPAC Acquisition | JVSA | Nov 7, 2024 | 10.38 | 0.00 |
JX Luxventure | JXJT | Nov 7, 2024 | 1.28 | -0.78 |
Kadant | KAI | Nov 7, 2024 | 387.14 | +0.51 |
Kairos Pharma | KAPA | Nov 7, 2024 | 1.37 | 0.00 |
Kairous Acquisition | KACL | Nov 7, 2024 | 12.30 | 0.00 |
Kaiser Aluminium | KALU | Nov 7, 2024 | 83.53 | -3.10 |
Kaival Brands Innovations Group | KAVL | Nov 7, 2024 | 0.90 | -1.65 |
Kaixin Holdings | KXIN | Nov 7, 2024 | 3.60 | -6.25 |
Kala Bio | KALA | Nov 7, 2024 | 6.87 | -2.55 |
Kaltura | KLTR | Nov 7, 2024 | 1.89 | +9.25 |
KalVista Pharmaceuticals | KALV | Nov 7, 2024 | 11.18 | -2.02 |
Kamada | KMDA | Nov 7, 2024 | 5.98 | -0.17 |
Kandi Technologies Group | KNDI | Nov 7, 2024 | 1.37 | +6.20 |
Kanzhun ADR | BZ | Nov 7, 2024 | 15.33 | +3.58 |
Karat Packaging | KRT | Nov 7, 2024 | 29.35 | -1.01 |
Karooooo | KARO | Nov 7, 2024 | 39.56 | -3.21 |
Kartoon Studios | TOON | Nov 7, 2024 | 0.73 | +1.04 |
Karyopharm Therapeutics | KPTI | Nov 7, 2024 | 0.88 | -0.50 |
Katapult | KPLT | Nov 7, 2024 | 7.11 | -4.76 |
Kayne Anderson BDC | KBDC | Nov 7, 2024 | 16.63 | -0.12 |
Kayne Anderson Energy Infrastructure Fund | KYN | Nov 7, 2024 | 12.56 | +1.87 |
Kazia Therapeutics ADR | KZIA | Nov 7, 2024 | 5.86 | -8.44 |
KB Financial Group ADR | KB | Nov 7, 2024 | 68.00 | +1.12 |
KB Home | KBH | Nov 7, 2024 | 80.40 | +0.61 |
KBR | KBR | Nov 7, 2024 | 70.81 | +1.16 |
KBW Bank Powershares | KBWB | Nov 7, 2024 | 67.39 | -2.71 |
KBW High Div Yield Financial Powershares | KBWD | Nov 7, 2024 | 15.28 | +0.53 |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 7, 2024 | 20.09 | -0.25 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 7, 2024 | 118.22 | -0.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.